What can the roll-out of a two-monthly HIV prevention injection learn from how the daily anti-HIV pill was introduced? Create demand, make the jab easy to get hold of and ensure it’s not stigmatised, write Wawira Nyagah and Mitchell Warren
PrEP is not a magic bullet. But we won’t end the HIV epidemic without it.
For the first time an Aids vaccine in our lifetime is possible, but scientists need money and support to make it work.